Phase I study of nemorubicin hydrochloride (nemorubicin), a novel DNA-intercalator, in combination with cisplatin in patients with unresectable hepatocellular carcinoma (HCC)

Izzo, F; Grosso, M; Middleton, M; Balestreri, L; Labianca, R; Catino, A; Valota, O; Laffranchi, B; Fiore, F

Journal article

Phase I study of nemorubicin hydrochloride (nemorubicin), a novel DNA-intercalator, in combination with cisplatin in patients with unresectable hepatocellular carcinoma (HCC)

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Izzo, F., Grosso, M., Middleton, M., Balestreri, L., Labianca, R., Catino, A., Valota, O., Laffranchi, B., & Fiore, F. (2007). Phase I study of nemorubicin hydrochloride (nemorubicin), a novel DNA-intercalator, in combination with cisplatin in patients with unresectable hepatocellular carcinoma (HCC). MOLECULAR CANCER THERAPEUTICS, 6(12), 3380S–3380S.

MLA Style

Izzo, F., et al. “Phase I Study of Nemorubicin Hydrochloride (Nemorubicin), a Novel DNA-Intercalator, in Combination with Cisplatin in Patients with Unresectable Hepatocellular Carcinoma (HCC).” MOLECULAR CANCER THERAPEUTICS, vol. 6, no. 12, 2007, pp. 3380S–3380S.

Chicago Style

Izzo, F, M Grosso, M Middleton, L Balestreri, R Labianca, A Catino, O Valota, B Laffranchi, and F Fiore. 2007. “Phase I Study of Nemorubicin Hydrochloride (Nemorubicin), a Novel DNA-Intercalator, in Combination with Cisplatin in Patients with Unresectable Hepatocellular Carcinoma (HCC).” MOLECULAR CANCER THERAPEUTICS 6 (12): 3380S–3380S.
Tweet
Print

Authors

+ Izzo, F More by this author

Role:

Author

+ Grosso, M More by this author

Role:

Author

+ Middleton, M More by this author

Institution:

University of Oxford

Division:

MPLS

Department:

Engineering Science

Sub department:

Institute of Biomedical Engineering

Role:

Author

+ Balestreri, L More by this author

Role:

Author

+ Labianca, R More by this author

Role:

Author

More authors...

Bibliographic Details

Journal:: MOLECULAR CANCER THERAPEUTICS
Volume:: 6
Issue:: 12
Pages:: 3380S-3380S
Publication date:: 2007-12-01
ISSN:: 1535-7163

Item Description

Pubs id:: pubs:119822
UUID:: uuid:36af4dee-7167-44e2-9cbc-353723bac618
Local pid:: pubs:119822
Source identifiers:: 119822
Deposit date:: 2013-11-16

Terms of use

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

Journal article

Phase I study of nemorubicin hydrochloride (nemorubicin), a novel DNA-intercalator, in combination with cisplatin in patients with unresectable hepatocellular carcinoma (HCC)

Actions

Authors

Bibliographic Details

Item Description

Terms of use

Metrics

Views and Downloads

Altmetrics

Dimensions